Table 2 Age- and sex-adjusted relative risk of different cancers between persons with positive and negative tissue transglutaminase antibodies (Celikey tTG) and endomysial antibodies (EMA)
Celikey tTGEMA
Celikey tTG-negative n = 6647Celikey tTG-positive n = 202p ValueEMA-negative n = 6776EMA-positive n = 73p Value
Cancer, all sites
    Cases671236895
    Relative risk (95% CI)*1.000.91 (0.60 to 1.37)0.641.000.67 (0.28 to 1.61)0.33
Lymphoproliferative disease
    Cases283292
    Relative risk (95% CI)*1.002.76 (0.83 to 9.16)0.151.005.94 (1.41 to 25.04)0.05
Gastrointestinal cancer
    Cases11561210
    Relative risk (95% CI)*1.001.38 (0.60 to 3.14)0.471.000.00 (–)0.12
Lung cancer
    Cases832850
    Relative risk (95% CI)*1.000.73 (0.18 to 2.97)0.641.000.00 (–)0.26
Breast cancer, women
    Cases†892901
    Relative risk (95% CI)*1.000.64 (0.16 to 2.59)0.491.000.71 (0.10 to 5.07)0.71
Prostate cancer, men
    Cases‡561570
    Relative risk (95% CI)*1.000.54 (0.07 to 3.90)0.501.000.00 (–)0.41
  • *Age- and sex-adjusted. †Only women at risk were included. ‡Only men at risk were included.